){kind=logo}
Loeb & Loeb is mentioned in a press release published on GlobeNewswire for representing Insud Pharma, a global pharmaceutical group, in a definitive merger with Agile Therapeutics, a women’s health care company.
The acquisition has an estimated value of $45 million and is expected to close in the third quarter of 2024.
For more information, please see GlobeNewswire’s website.